UBS Group »

Eikon Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Eikon Therapeutics (EIKN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.1M 99k 10.58

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Eikon Therapeutics

FMR
BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
Alliancebernstein
Vanguard Capital Management
EcoR1 Capital
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board
Franklin Resources
Citadel Advisors

View all funds holding Eikon Therapeutics